Positron emission tomography (PET) is a sensitive and noninvasive in vivo molecular imaging modality. Fluorine-18 (  18 F) has favorable physical properties to generate high-resolution PET images and consequently 18 F-labeled compounds are the most used tracers in clinical PET. Among the short-lived radionuclides, the physical half-life of 18 F (T 1/2 = 109.7 minutes) allows multi-step synthesis of tracers for the same-day use in hospitals.
1 Versatile fluorinating agents have been developed for the synthesis of fluorine containing pharmaceuticals. . VAP-1 is a 90 kDa glycoprotein and is a unique target in inflammation. 6 Inflammation is highly relevant in major diseases including cancer, diabetes, obesity and Alzheimer's disease. 6b In endothelial cells, VAP-1 stays in the intracellular storage granules under normal physiological conditions. Upon inflammation, VAP-1 relocates rapidly to the endothelial cell surface. This makes VAP-1 an ideal target for diagnostic imaging of inflammation. Recently, it has been discovered that sialic acid-binding Ig-like lectin 9 (Siglec-9) is a leukocyte ligand of VAP-1 and 68
Ga-labeled Siglec-9 motif peptide can be used as a PET tracer for in vivo imaging of inflammation and cancer. 7 (0.6 mg ml À1 ) and the conversion was 95% in 10 min at rt. The concentration of the anilinium buffer also had an influence on the conjugation efficiency (entries 2-4). Our results together with the previous work demonstrated that aniline-catalyzed oxime formation is chemoselective in the presence of any amino acid side chain from all the 20 standard amino acids under 18 F-labeling conditions. a The two reagents were used in equal amounts. b Conversions were determined using HPLC. 
